Phage down under: stability of a travelling phage

Issue 179 | June 10, 2022
13 min read
Capsid and Tail

What we learned from sending Pae7, Phage Australia’s first produced phage, all around Australia!

The Phage Australia network recently shipped a purified phage to collaborators across the country, and had everyone titre it and report back. Stephanie Lynch, who spearheaded this effort, tells us what was done and what the team learned.

This post coincides with the launch of Phage Australia’s brand new website! Check it out at


PF EU download report

As we look forward to the 2022 Phage Futures Europe event, 6-7 July in Amsterdam, take a look at the 2021 post-event report, created in collaboration with PhD students from Phage Directory, Sheetal Patpatia and Aël Hardy, to gain insight into phage manufacturing, phage matching and more.

Delve deeper into these conversations at the Phage Futures 2022 event and explore new areas including new clinical data from Eligo Bioscience, Intralytix, PhageLux, improving formulation and manufacturing, computational approaches to phage cocktail design, methods for scaling up, regulatory considerations and more.

What’s New

Pre-print: Subtherapeutic doses of vancomycin synergize with bacteriophages for treatment of experimental methicillin-resistant Staphylococcus aureus infective endocarditis

In vivo interactionsPhage-antibiotic synergyPreprint

Paper: PhREEPred: Phage Resistance Emergence Prediction web to foresee encapsulated bacterial escape from phage cocktail treatment

Phage resistanceResearch paperVirus tools

Paper: Diversity of lytic bacteriophages against XDR Klebsiella pneumoniae sequence type 16 recovered from sewage samples in different parts of the world

Bacteriophage isolationPhage genomicsResearch paper

Paper: Suggestion for a new bacteriophage genus for the Klebsiella pneumoniae phage vB_KpnS-Carvaje

Phage biologyPhage genomicsResearch paper

Paper: Topical liquid formulation of bacteriophages for metered-dose spray delivery

FormulationPhage biologyResearch paper

Latest Jobs

Sponsored Ad EndolysinsResearch Lead
Research Lead: Join BioNTech’s team in Vienna (Austria) as Research Lead to work on the early endolysin pipeline! In this position you can advance your career of leadership in science, push the boundaries of synthetic biology and work on the next frontier of antimicrobial therapy.
PhD projectViral ecologyWaste water
PhD project to study viral ecology to combat problem organisms in biological wastewater treatment
Molecular BiologyPhD projectPhage cocktail developmentUTI
PhD project to explore the molecular biology of UTI phage cocktails
PhD projectPhage cocktail developmentPhage mutations
PhD project to study localised mutations to expand the host range of phage cocktails against Pseudomonas aeruginosa.
Gut microbiomeHorizontal gene transferPhage biologyPost Doc
Postdoc to join APC Microbiome to investigate the role of phages in horizontal gene transfer in the human gut microbiome.

Community Board

Anyone can post a message to the phage community — and it could be anything from collaboration requests, post-doc searches, sequencing help — just ask!

Introducing Phage Australia

Phage Australia’s new website is live at!

Phage Australia is a national network of phage researchers and clinician scientists who aim to professionalise phage therapy as the third major intervention for infectious diseases.

To do this, Phage Australia is building a national ecosystem that integrates phage biobanking, rapid phage diagnostics, phage manufacturing, and an adaptive clinical trial framework that fits the context of personalized phage therapy.

Read more about Australia’s phage therapy network!

iVoM Season 2, hosted by ISVM, VoM 2022 and Phage Directory concluded recently with its 7th event.

The recordings of all the events are now posted on the members page!

The events spanned all aspects of viruses of microbes, and each feature 3 x 10 min talks followed by a combined Q&A and topic discussion.

If you’d like to see these videos but didn’t attend the series, you can still register here.

Given that VoM 2022 is approaching next month, after a 2-year hiatus due to COVID, it’s a great time to catch up on everything viruses-of-microbe!

Thanks so much to all who joined and to our speakers and chairs!

iVoMISVMViruses of Microbes

Phage down under: stability of a travelling phage

Profile Image
Postdoctoral Researcher
Iredell Lab, The Westmead Institute for Medical Research, Sydney, Australia, Phage Australia

Stephanie is a postdoctoral researcher for the Iredell Group at Westmead Institute for Medical Research, NSW. Her project focuses on phage therapy for compassionate human cases (as part of Phage Australia), with a particular interest in Staphylococcal phages. In 2021, Stephanie completed her thesis titled ‘Exploring phage therapy for Staphylococcus pseudintermedius infections in canines’. Steph is always willing to chat about phage research and would like to connect with phage biotech companies.

Before we start, I want to thank the following:

For receiving the phage and collecting data:

  • Anthony Kicic and Renee Ng, Telethon Kids Institute, WA;
  • Jeremy Barr and Dinesh Subedi, Monash University, VIC;
  • Peter Speck and Legesse Garedew, Flinders University, SA;
  • Rachel (Yoon) Chang and Becky Li, University of Sydney, NSW

For help designing the experiment:

  • Jessica Sacher, Ruby Lin and Jon Iredell, Westmead Institute for Medical Research, NSW

For purifying the phage:

  • Ali Khalid, Helene Lebhar, Chris Marquis at University of New South Wales, NSW

What is Phage Australia and why did they send phage across Australia?

Phage Australia (check out our new website here!) is a national network (#AusPhageNet) of phage researchers, scientists, and clinicians who aim to professionalise phage therapy as the third major intervention for infectious diseases, after vaccines and antibiotics. While Phage Australia is led by Professor Jon Iredell at Westmead Hospital/Westmead Institute for Medical Research, the network is supported by various collaborative phage research teams across Australia.

As the network is dispersed across the country, this study was designed to send a purified Pseudomonas phage (Pae7) around Australia, to gain information about the shipping process and see how shipment may affect the titre of Pae7! This study demonstrates the beginning of our functional phage exchange network, along with a harmonised data collection system, starting with shipments between research labs within Australia.

What do we know about Pseudomonas phage Pae7?

Pae7 is a Pseudomonas phage that was isolated from sewage by researchers at Westmead Institute for Medical Research, Sydney, Australia (Ali Khalid, Matthew Smith, and Aleksandra Petrovic Fabijan). Confirmed through whole-genome sequencing (WGS), Pae7 is lytic, and belongs to the Myoviridae family, within the order ‘Caudovirales’. On its propagation host, PAO1, phage Pae7 produces medium-sized plaques that display a clear centre surrounded by a hazy ‘halo’ (Figure 1).

figure 1
Figure 1. Characteristics and plaque morphology of Pseudomonas phage, Pae7.

Pae7 was chosen to be sent across the network as it is the first phage to be purified using our new phage purification protocol, carried out by Ali Khalid and the School of Biotechnology & Biomolecular sciences (BABS) team at the University of New South Wales (UNSW). An overview of the purification process can be found on Twitter here.

How did we go about sending Pae7 across the country?

  • On Monday (25 April 2022) prior to sending out Pae7, the research team at Westmead checked the titre of Pae7 (2.0 x 10^8 PFU/mL).
  • On Tuesday (26 April 2022), Pae7 was shipped using the company ‘World Courier’ to the participating teams in a 850 mL bio-bottle screw-top container containing;
    • 1 x frozen ice-pack
    • 2 x 1 mL Pae7 in screw-top cryotubes
    • 1 x swab containing PAO1 (bacterial host of Pae7)
  • Upon receiving the shipment, teams were provided with a protocol to titre Pae7 (as depicted in Figure 2 below).
  • Results from each team were documented and shared through photos of the plates to show the titre of Pae7.

figure 2
Figure 2. Workflow of receiving and checking the titre of Pae7. 1) Each team received a bio bottle containing an ice pack, two cryotubes with Pae7 (2.0 x 10^8 PFU/mL) and a swab of PA01 (Pae7 host). 2) The teams were directed to grow PAO1 from the swab onto LB agar and incubate the plate overnight at 37c. 3) With the growth of PAO1 on LB, the teams were directed to create a day culture by inoculating 3 pure colonies into 3 mL LB. 4) Once the culture was at the mid-log phase, 300 uL of the culture was added to 5mL molten overlay (containing 1mM CaCl2) and poured onto a solid LB agar plate. 5) Pae7 was diluted down to 10^-8, spotted onto the set overlay plate and incubated at 37c overnight. 6) Following incubation, the plaques were counted and plugged into a calculation to estimate the titre of Pae7.

So, what did we learn from this?

Pae7 took 24 hours to reach the furthest location we shipped to

  • It took ~3 hours to reach collaborators at the University of Sydney, NSW (~27 km distance), which was the closest destination (Figure 3)
  • It took ~24 hours to reach Monash University, VIC (~874 km distance), Flinders University, SA (~1,359 km distance) & Telethon Kids Institute, WA (~3,921km distance) (Figure 3).

figure 3
Figure 3. Shipment times of Pae7 to Phage Australia network. The red location pin shows the approximate location of Westmead Institute for Medical Research, NSW, where Pae7 was shipped from. The black location pins show the 4 locations that received Pae7; Location 1: The University of Sydney, NSW, Location 2: Monash University, VIC, Location 3: Flinders University, SA, Location 4: Telethon Kids Institute, WA.

The time required for various geographical locations to receive Pae7 was an important finding, as it would allow us to better plan phage shipments in the future. It would also be interesting for us to get clues about whether the titre of Pae7 might be influenced by location/time taken for Pae7 to travel (e.g. would a longer shipping time result in a lower titre of Pae7 on arrival). However, it should be noted that there may have been unforeseen temperature fluctuations even at room temperature shipping that were not controlled for here.

The observed titre of Pae7 spanned a ~1-2 log range

  • Researchers that received Pae7 were asked to titre the stock on arrival using the methods outlined in Figure 2.
  • When Pae7 was shipped from Westmead Institute, the titre was recorded as 2 x 10^8 PFU/mL (Figure 4a)
  • The first location to receive Pae7 was the University of Sydney, NSW (arrived ~3 hrs after shipping), where researchers recorded a titre of 3.8x10^7 PFU/mL (-0.72 log drop). (Figure 4a)
  • The next three locations to receive Pae7 were Telethon Kids Institute, WA, Flinders University, SA and Monash University, VIC. Pae7 arrived ~24 hrs after shipping and the researchers recorded a titre of 1.85 x 10^7 PFU/mL (-1.03 log drop) (Telethon Kids, WA), 1.0 x 10^6 PFU/mL (-2.30 log drop) (Flinders University, SA) and 1.2 x 10^7 PFU/mL (-1.22 log drop) (Monash University, VIC). (Figure 4a)
  • We saw an average drop of 1.3 log PFU/mL, and max drop of 2.3 logs (Flinders University).
  • The distance and time taken to receive Pae7 don’t appear to correlate with the magnitude of the drop in titre.
  • Even being transported across the same city led to a 0.72-log drop

figure 4
Figure 4. Titre of Pae7 from various teams across Australia. A) The titre of Pae7 was recorded at Westmead Institute, NSW prior to sending. The titre of Pae7 was recorded upon receiving Pae7. B) Image of the plaque-forming count of Pae7 on PAO1 by Renee Ng, Telethon Kids Institute, WA.

Salt concentration in media may influence Pae7 titre, plaque formation, and PAO1 pigmentation

While we noted that distance traveled or time taken to receive Pae7 didn’t seem to affect the titre of Pae7, a PhD student at Telethon Kids Institute, Renee Ng, took a deep dive into what other factors may affect the titre, plaque morphology and growth of PAO1.

Here is what she found:

  • PAO1 grown in LB overlay with different salt concentrations affects pigmentation slightly: it appears that PAO1 has a yellow-green colouring when grown in LB Miller overlay, compared to showing a green-blue colouring when grown in LB Lennox overlay.
  • The two different LB formulations affected Pae7 titre: Renee noted a ~1-log reduction in Pae7 titre when using LB Miller overlay (10g/L NaCl) compared to LB Lennox (5 g/L NaCl)
  • It is important to note here that LB Miller and LB Lennox contain the same ingredients: Tryptone, Yeast Extract and Sodium Chloride, however, LB Miller has twice the amount of Sodium Chloride as LB Lennox (10 g/L vs 5 g/L)

figure 5
Figure 5. PAO1 on LB Miller (left) compared to LB Lennox (right).

Concluding remarks

Overall, this experience helped us get a sense of what to expect when shipping phages around Australia, and the approximate range in titre that we should expect to see. Since we’ll be doing this a lot in the future as the Phage Australia network gets up and running, it’s good to know that even using a standardized protocol that labs have experience with, and the exact same strains and phage, and only 24 h in transit, we can see a 1-2 log range in phage titres.

These results also provide some unexpected and interesting insights into other factors that may affect the titre of Pae7 beyond the distance of shipping or time taken to receive the phage, such as the brand of media a lab uses.

Lastly, these results also show what a ‘peer-replicate’ system could look like for phage lab work, showing a taste of the value that a network like Phage Australia can bring if we have a system in place for validating each other’s work. (More on this to come as we develop Phage Australia’s phage exchange program!)

Learn more about Phage Australia

We’re excited to launch our new website for Phage Australia today! Check out to learn more about what we’re building!

Capsid & Tail

Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.

We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.

Sign up for Phage Alerts

In collaboration with

Mary Ann Liebert PHAGE

Supported by

Leona M. and Harry B. Helmsley Charitable Trust

Crossref Member Badge